Evidence map›Paper›PMID 40835238›Full record

ArticleBMJ open ophthalmology2025

Corneal enzymatic digestion resistance in the presence of oestradiol and oestradiol plus selective tissue oestrogenic activity regulators (STEAR).

Nikki L Hafezi, M Enes Aydemir, Nan-Ji Lu, Emilio A Torres-Netto, Mark Hillen, Carina Koppen

Abstract read
In one paragraph

Article in BMJ open ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nikki L HafeziFaculty of Medicine, University of Antwerp, Wilrijk, Antwerp, Belgium nhafezi@elza-institute.com.ORCID 0000-0002-6240-4110
M Enes AydemirELZA Institute, Zurich, Switzerland.
Nan-Ji LuFaculty of Medicine, University of Antwerp, Wilrijk, Antwerp, Belgium.
Emilio A Torres-NettoELZA Institute, Zurich, Switzerland.
Mark HillenELZA Institute, Zurich, Switzerland.
Carina KoppenDepartment of Ophthalmology, Antwerp University Hospital, Edegem, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveElevated oestrogen levels and pharmacotherapies targeting oestrogen receptors can reduce corneal biomechanical stability, and altered stromal collagenase activity has been identified as one the possible mechanisms. We wished to determine the impact of oestradiol and the selective tissue (o)estrogenic activity regulator (STEAR), tibolone, on corneal enzymatic digestion resistance. METHODS AND ANALYSIS: Freshly prepared ex vivo porcine corneas (n=48) were divided into three groups. Group A corneas served as untreated controls. Group B corneas were incubated in 20 µmol/L oestradiol solution and group C corneas were incubated in 20 µmol/L oestradiol solution with 2.5 mg tibolone before digestion in 0.3% collagenase-A solution to assess digestion time until corneal button dissolution.

resultsGroup A control corneas showed the strongest resistance to collagenase digestion (31.38±2.03 hours). Corneas from group B that were preconditioned with oestradiol showed significantly lower resistance to digestion than group A control corneas (27.25±1.84 hours, p<0.01). Group C corneas that had been pretreated with both oestradiol and tibolone showed the least resistance to digestion (22.38±2.47 hours), with significant differences to group B (p<0.01) and group A (p<0.01).

conclusionOestradiol significantly reduces corneal enzymatic digestion resistance. When combined with the STEAR, tibolone, there is a further decrease in stromal enzymatic digestion resistance. These results suggest that high oestradiol levels could have a significant impact on corneal conditions characterised by elevated collagenase activity, such as corneal ectasias (eg, keratoconus) and infectious keratitis. Importantly, the employment of STEAR therapy, such as tibolone, may amplify the effects of oestradiol.

Indexed as

CollagenasesCorneaCorneal StromaEstradiolEstrogensNorpregnenesSelective Estrogen Receptor ModulatorsAnimalsSwineCollagenasesEstradiolEstrogensNorpregnenesSelective Estrogen Receptor Modulatorstibolonecorneaexperimental & laboratory

Identifiers

PMID40835238
PMCPMC12366596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.